Reply 125659 Belieze, while you make a point it/they won't have an effect on the final outcome. IMO. The probability of a circuitous path to a buyout is very, very high. Too many variables, but there are obvious players. MDT doesn't have the upper hand by any stretch of the imagination. Which is why the payoff date is so far out, unless the alternate provisions occur first. That's a delay tactic so TMDI can't be bought by anyone else before then, except by MDT.
1) MDT doesn't own 30% of any part of TMDI. They're licensing 30% of TMDI's IP. That's all. TMDI owns it.
2) If you think MDT owns any stock in TMDI, that's TBD and doesn't appear to be more than 5% in MDT's name. While institutional buyers may be friendly to MDT, they'll go with a higher bid from a different company. You wouldn't agree to a higher BO price?
3) It's pretty obvious your agenda is to emphasize all aspects of the negative side of this company, how it's mis-managed and the difficulties and travails. Waste of time and effort.
4) You keep missing the bid picture. IMO. TMDI has the ability to be purchased by anyone after the loan is paid. They just can't license the IP to another competitor to generate more revenue. It only takes one competitor to take the BO to +5B. And the IP is worth that alone because of how unique it is. Remember there's an MDT person on the board. They're in attendance to provide as much advance warning if a competitor starts a conversation. It permits MDT to make the first move. It won't be a low-ball offer. Remember - it's Martha's reputation at stake here. He's newly appointed. He needs a big-picture victory to be a successful CEO for a long time. No one will care if he over pays for great assets, so long as MDT owns those assets. Besides the BOD has to know in advance to approve the price. It's all about future revenue. TMDI is developing it's R&D know how as much as it's finishing ENOS. Is anyone impressed by HUGO? Martha probably would hedge his bets for another R&D lab to develop future RAS devices. So TMDI has 3 big exclusive assets. ENOS, Titan Labs and the IP.
5) Do you think any competitor will just let MDT walk away with TMDI without so much as a counter-offer? Institutional investors would scream for a bidding war. They're the audience in this theater.
JMO. Regards,BK.
AI
